A prospective, randomized, multicenter, open- label, two-arm and parallel-group Study to evaluate the efficacy and safety of Nicotinamide DS compared to Ciclopiroxolamine cream at 1% in patients affected by seborrheic dermatitis

Copyright © 2020 LNAGE S.R.L. - TUTTI I DIRITTI RISERVATI
per contatti riguardanti lo Studio IDI IDI@lnage.it